## Answer
(model generated chain of thought explanation)

Given the clinical presentation of this patient, which includes numerous poorly demarcated skin lesions, significant facial thickening, eyebrow loss, symmetrical sensory neuropathy in a 'glove and stocking' distribution, bilateral weakness, and positive acid-fast bacilli culture from the skin biopsy, the most likely diagnosis is leprosy.

Leprosy, also known as Hansen's disease, is a chronic bacterial infection caused by Mycobacterium leprae. The treatment for leprosy typically involves a combination of antibiotics to eliminate the bacteria from the body.

The first-line treatment for multibacillary leprosy (which this patient likely has due to the widespread nature of his symptoms) includes rifampicin, dapsone, and clofazimine. However, given that the skin biopsy is positive for acid-fast bacilli, which are characteristic of M. leprae, the addition of dapsone is crucial.

Dapsone is a key component of the treatment regimen for leprosy because it has bactericidal activity against M. leprae and can also help to reduce the symptoms of the disease by reducing inflammation and preventing further nerve damage.

The other options are not correct in this context:

- Flucloxacillin is an antibiotic used primarily to treat bacterial skin infections, such as staphylococcal scalded skin syndrome (SSSS), which does not match the patient's presentation.
- Isoniazid is a first-line antitubercular agent that may be used in combination with other drugs for leprosy treatment but is not the primary component of the treatment regimen for multibacillary leprosy.
- Prednisone, while it can be used to treat some forms of skin inflammation and nerve damage associated with leprosy, is not a standard part of the treatment regimen.

Therefore, the correct answer is A. Dapsone.